Collected Strategies Advises Exact Sciences on $23B Sale

Collected Strategies advised Exact Sciences with its announcement that it entered into a definitive agreement to be acquired by Abbott. The transaction, which is valued at approximately $23 billion including debt, will enable Abbott to enter and lead in the fast-growing cancer diagnostics segment.

Read more about the transaction in O'Dwyer's.

‍